Desentum Oy
🇫🇮Finland
- Country
- 🇫🇮Finland
- Ownership
- Holding
- Established
- 2011-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.desentum.fi
Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)Study to Evaluate Safety, Tolerability and Explorative Efficacy of DM-101PX in Birch Pollen Allergic Participants
Phase 1
Completed
- Conditions
- Birch Pollen Allergy
- First Posted Date
- 2023-09-14
- Last Posted Date
- 2024-03-25
- Lead Sponsor
- Desentum Oy
- Target Recruit Count
- 30
- Registration Number
- NCT06037148
- Locations
- 🇨🇦
Cliantha Research, Mississauga, Ontario, Canada
Study to Evaluate Safety and Tolerability of sc Immunotherapy With DM-101 in Adults With Birch Pollen Allergy
Phase 1
Completed
- Conditions
- Birch Pollen Allergy
- First Posted Date
- 2020-02-12
- Last Posted Date
- 2023-03-21
- Lead Sponsor
- Desentum Oy
- Target Recruit Count
- 27
- Registration Number
- NCT04266028
- Locations
- 🇫🇮
Clinical Research Services Turku, Turku, Finland
News
No news found